Andere Sprachen Bio-Techne Corporation

Aktien

A12ENG

US09073M1045

TECH

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 26.04.2024			% 5 Tage	% 1. Jan.
64,06 ^USD	+2,23 %		+3,12 %	-16,98 %

26.04.	Bio-Techne Corporation und Novomol-Dx kündigen Point-of-Care-Augenbiomarker-Assay an	CI
18.04.	BIO-TECHNE CORPORATION : Deutsche Bank Securities bleibt neutral	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY	26.04.
Bio-Techne Corporation and Novomol-Dx Announce Point-of-Care Ocular Biomarker Assay	26.04.
Bio-Techne Says It Filed Patent Infringement Lawsuit Against Molecular Instruments in Europe	23.04.
BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS	23.04.
BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS	10.04.
BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY	08.04.
BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS	01.04.
Bio-Techne Positioned for Growth Amid Biotech Funding Recovery, UBS Says	28.03.
BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES	28.03.
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA	25.03.
Bio-Techne Says European Union IVDR Certification Received for Diagnostic Test Tracking Chronic Myeloid Leukemia	22.03.
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA	22.03.
BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES AND MEDTECH INVESTOR FORUM	13.03.
BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM	12.03.
BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE	06.03.
Année faste en 2023 pour les levées de fonds à l'EPFL	12.02.
North American Morning Briefing : Hopes of March -2-	05.02.
Bio-Techne Seeks M&A	01.02.
Bio-Techne's Fiscal Q2 Adjusted Earnings Fall, Net Sales Rise	01.02.
Earnings Flash (TECH) BIO-TECHNE CORPORATION Reports Q2 Revenue $272.6M, vs. Street Est of $277.7M	01.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Bio-Techne Corporation

Aktien

A12ENG

US09073M1045

TECH

Andere Sprachen

Filter